BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 10660541)

  • 21. Dual inhibition of HY023016 based on binding properties of platelet membrane receptor subunit glycoprotein Ibα and thrombin exosites.
    Chen QF; Cui S; Shen HL; Chen X; Li YZ; Wu Q; Xu YG; Gong GQ
    Eur J Pharmacol; 2018 Mar; 822():51-58. PubMed ID: 29355554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crystal structure of the GpIbalpha-thrombin complex essential for platelet aggregation.
    Dumas JJ; Kumar R; Seehra J; Somers WS; Mosyak L
    Science; 2003 Jul; 301(5630):222-6. PubMed ID: 12855811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-activity relationships of snake toxins targeting platelet receptors, glycoprotein Ib-IX-V and glycoprotein VI.
    Andrews RK; Gardiner EE; Shen Y; Berndt MC
    Curr Med Chem Cardiovasc Hematol Agents; 2003 Jun; 1(2):143-9. PubMed ID: 15320694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The many faces of platelet glycoprotein Ibalpha--thrombin interaction.
    Kobe B; Guncar G; Buchholz R; Huber T; Maco B
    Curr Protein Pept Sci; 2009 Dec; 10(6):551-8. PubMed ID: 19751194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombin binding to GPIbalpha induces platelet aggregation and fibrin clot retraction supported by resting alphaIIbbeta3 interaction with polymerized fibrin.
    Dubois C; Steiner B; Kieffer N; Reigner SC
    Thromb Haemost; 2003 May; 89(5):853-65. PubMed ID: 12719784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics of the interaction between thrombin exosite 1 and the sequence 269-287 [correction of 269-297] of platelet glycoprotein Ibalpha.
    Bouton MC; Thurieau C; Guillin MC; Jandrot-Perrus M
    Thromb Haemost; 1998 Aug; 80(2):310-5. PubMed ID: 9716158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombin induces platelet activation in the absence of functional protease activated receptors 1 and 4 and glycoprotein Ib-IX-V.
    Lova P; Canobbio I; Guidetti GF; Balduini C; Torti M
    Cell Signal; 2010 Nov; 22(11):1681-7. PubMed ID: 20600849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding of heparin to platelet membrane glycoprotein Ib: functional effects.
    Jandrot-Perrus M; Clemetson KJ; Guillin MC; Bouton MC
    Thromb Haemost; 1999 Feb; 81(2):316-7. PubMed ID: 10064015
    [No Abstract]   [Full Text] [Related]  

  • 29. Binding of platelet glycoprotein Ibalpha to von Willebrand factor domain A1 stimulates the cleavage of the adjacent domain A2 by ADAMTS13.
    Nishio K; Anderson PJ; Zheng XL; Sadler JE
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10578-83. PubMed ID: 15249683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. cAMP- and cGMP-elevating agents inhibit GPIbα-mediated aggregation but not GPIbα-stimulated Syk activation in human platelets.
    Makhoul S; Trabold K; Gambaryan S; Tenzer S; Pillitteri D; Walter U; Jurk K
    Cell Commun Signal; 2019 Sep; 17(1):122. PubMed ID: 31519182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombocytopathy leading to impaired in vivo haemostasis and thrombosis in platelet type von Willebrand disease.
    Kaur H; Corscadden K; Ware J; Othman M
    Thromb Haemost; 2017 Feb; 117(3):543-555. PubMed ID: 28004055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet physiology and thrombosis.
    Andrews RK; Berndt MC
    Thromb Res; 2004; 114(5-6):447-53. PubMed ID: 15507277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cleaved peptide of PAR1 results in a redistribution of the platelet surface GPIb-IX-V complex to the surface-connected canalicular system.
    Furman MI; Nurden P; Berndt MC; Nurden AT; Benoit SE; Barnard MR; Ofosu FA; Michelson AD
    Thromb Haemost; 2000 Nov; 84(5):897-903. PubMed ID: 11127874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycoprotein Ibalpha-mediated platelet adhesion and aggregation to immobilized thrombin under conditions of flow.
    Weeterings C; Adelmeijer J; Myles T; de Groot PG; Lisman T
    Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):670-5. PubMed ID: 16357309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thrombin-induced platelet activation is inhibited by high- and low-molecular-weight heparin.
    De Candia E; De Cristofaro R; Landolfi R
    Circulation; 1999 Jun; 99(25):3308-14. PubMed ID: 10385507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A fragment of antithrombin that binds both heparin and thrombin.
    Rosenfeld L; Danishefsky I
    Biochem J; 1986 Aug; 237(3):639-46. PubMed ID: 3800906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The GPIb thrombin-binding site is essential for thrombin-induced platelet procoagulant activity.
    Dörmann D; Clemetson KJ; Kehrel BE
    Blood; 2000 Oct; 96(7):2469-78. PubMed ID: 11001899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular cloning and characterization of rhesus monkey platelet glycoprotein Ibα, a major ligand-binding subunit of GPIb-IX-V complex.
    Qiao J; Shen Y; Shi M; Lu Y; Cheng J; Chen Y
    Thromb Res; 2014 May; 133(5):817-25. PubMed ID: 24560895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human factor XII binding to the glycoprotein Ib-IX-V complex inhibits thrombin-induced platelet aggregation.
    Bradford HN; Pixley RA; Colman RW
    J Biol Chem; 2000 Jul; 275(30):22756-63. PubMed ID: 10801853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet adhesion to dimeric beta-glycoprotein I under conditions of flow is mediated by at least two receptors: glycoprotein Ibalpha and apolipoprotein E receptor 2'.
    Pennings MT; Derksen RH; van Lummel M; Adelmeijer J; VanHoorelbeke K; Urbanus RT; Lisman T; de Groot PG
    J Thromb Haemost; 2007 Feb; 5(2):369-77. PubMed ID: 17096706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.